Literature DB >> 26678198

Precision medicine: lessons learned from the SHIVA trial.

Andrew W Hahn1, Mike G Martin2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26678198     DOI： 10.1016/S1470-2045(15)00458-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

Review 1.  Histology-agnostic drug development - considering issues beyond the tissue.

Authors:  Roberto Carmagnani Pestana; Shiraj Sen; Brian P Hobbs; David S Hong
Journal:  Nat Rev Clin Oncol       Date:  2020-06-11       Impact factor: 66.675

2.  Concomitant ATM Mutations Identified by Next Generation Sequencing in a Patient With New-Onset Acute Myeloid Leukemia Following Imatinib Treatment for Chronic Myeloid Leukemia.

Authors:  Matthew K Stein; Melissa Crawley; Eric Vick; Mike G Martin
Journal:  World J Oncol       Date:  2018-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.